Two-electron reduction of penta(organo)[60]fullerenes C(60)Ar(5)H (Ar = Ph and biphenyl) by potassium/mercury amalgam afforded potassium complexes of the corresponding open-shell radical dianions [K+(thf)n]2[C60Ar5(2-.)]. These compounds were characterized by UV-visible-near-IR and electron spin resonance spectroscopy in solution. Anaerobic crystallization of [K+(thf)n]2[C60(biphenyl)(5)(2-.)] that exists largely as a monomer in solution gave black crystals of its dimer [K+(thf)3]4[(biphenyl)5C60-C60(biphenyl)5(4-)], in which the two fullerene units are connected by a C-C single bond [1.577(11) A] as determined by X-ray diffraction. Three-electron reduction of C60Ar5H with metallic potassium gave a black-green trianion [K+(thf)n]3[C60Ar5(3-)]. The reaction of the trianion with an alkyl halide RBr (R = PhCH(2) and Ph(2)CH) regioselectively afforded a hepta-organofullerene C60Ar5R2H, from which a potassium complex [K+(thf)n][C60(biphenyl)5(CH2Ph)(2)(-)] and a palladium complex Pd[C60(biphenyl)5(CH2Ph)2](pi-methallyl) as well as octa-organofullerene compounds C60(biphenyl)5(CH2Ph)3H2 and Ru[C60(biphenyl)5(C2Ph)3H]Cp were synthesized. These compounds possess a dibenzo-fused corannulene pi-electron conjugated system and are luminescent.
No takes yet. Share an insight, caveat, or question.
Matsuo et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: